Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EpiDestiny logo — Creating epigenetic treatments that align with nature for im...

EpiDestiny

Creating epigenetic treatments that align with nature for impactful and compassionate care of sickle cell, thalassemia, and cancer.

Founded 2016 Biotechnology, Health Care +1

General Information

Company Name EpiDestiny
Founded Year 2016
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when EpiDestiny moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EpiDestiny

EpiDestiny is a biotechnology startup founded in 2016, dedicated to creating epigenetic treatments that align with nature for impactful and compassionate care of sickle cell, thalassemia, and cancer. The company's slogan emphasizes their focus on developing non-cytotoxic epigenetic drugs that work with nature, not against it, to kindly and meaningfully treat these challenging diseases. EpiDestiny operates in the biotechnology, health care, and pharmaceutical industries, positioning itself at the forefront of innovative medical solutions. With an underlying commitment to addressing critical medical needs, EpiDestiny's approach to treatment represents a potential shift in the paradigm of healthcare. By developing therapies that prioritize the natural balance of the body, the company is working towards more sustainable and effective treatments for a range of debilitating illnesses. Although specific details regarding the company's headquarters, last investment, and investors are not highlighted, EpiDestiny's mission and focus on compassionate care and innovation present an intriguing opportunity for investment in the rapidly evolving biotechnology and pharmaceutical sectors.

Taxonomy: epigenetic treatments, nature-aligned drugs, sickle cell, thalassemia, cancer, non-cytotoxic drugs, compassionate care, epigenetic drugs, biopharmaceuticals, precision medicine

No funding data available for EpiDestiny yet.

Get notified when EpiDestiny raises funding

EpiDestiny Alternatives & Competitors

EpiDestiny vs
MyDNAge (Epimorphy LLC)
MyDNAge (Epimorphy LLC) United States

The gold standard of biological age tests. Revolutionizing the path to healthy aging.

3 employees
Health Care
EpiDestiny vs
Epigenic Therapeutics
Epigenic Therapeutics China

Pioneering Epigenetic Medicine

Series A
13 employees
Biotechnology
EpiDestiny vs
Clock Foundation
Clock Foundation

Advancing the science of epigenetic aging clocks to predict healthspan and lifespan, while making te...

3 employees
Biopharma, Biotechnology

FAQ About EpiDestiny

Creating epigenetic treatments that align with nature for impactful and compassionate care of sickle cell, thalassemia, and cancer.
EpiDestiny was founded in 2016.
EpiDestiny operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Top alternatives and competitors to EpiDestiny include MyDNAge (Epimorphy LLC), Epigenic Therapeutics, Clock Foundation, Moonwalk Biosciences, Hongjitang. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EpiDestiny and MyDNAge (Epimorphy LLC) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EpiDestiny and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy